Clinical pharmacology of the 6-thiopurines
- 1 June 1979
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 6, 19-25
- https://doi.org/10.1016/s0305-7372(79)80006-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Improved biochemical assay for terminal deoxynucleotidyl transferase in human blood cells: Results in 89 adult patients with lymphoid leukemias and malignant lymphomas in leukemic phaseLeukemia Research, 1978
- Inhibition of nucleoside uptake in HeLa cells by nitrobenzylthioinosinateBiochemical Pharmacology, 1978
- Combination chemotherapy: treatment of the Ehrlich ascites carcinoma and several drug-resistant sublines with combinations of 6-mercaptopurine and 6-(methylmercapto)purine ribonucleosideCanadian Journal of Biochemistry, 1970
- 2 The Biochemical Basis for the Drug Actions of PurinesProgress in Medicinal Chemistry, 1970
- Biochemistry of Cancer (Metabolic Aspects)Annual Review of Biochemistry, 1963
- Potentiation by inhibition of drug degradation : 6-substituted purines and xanthine oxidaseBiochemical Pharmacology, 1963
- The Comparison of 6-Mercaptopurine with the Combination of 6-Mercaptopurine and Azaserine in the Treatment of Acute Leukemia in Children: Results of a Cooperative StudyBlood, 1960
- Clinical Evaluation of a New Antimetabolite, 6-Mercaptopurine, in the Treatment of Leukemia and Allied DiseasesBlood, 1953
- Studies on Condensed Pyrimidine Systems. IX. The Synthesis of Some 6-Substituted PurinesJournal of the American Chemical Society, 1952